Fibrinogen Concentrates Market value is projected to reach US$ 4.28 Bn. at the end of the forecast period and it is expected to grow at the CAGR of 5.9%.Fibrinogen Concentrates Market Definition:
The main contributing factor to this market is the growing incidence of bleeding disorders and an upsurge in the number of approvals associated to fibrinogen concentrate. The congenital fibrinogen deficiency segment is projected to grow at a CAGR of xx % for the duration of the forecast duration. The North America region was valued US$ xx Mn in 2022 and is expected to reach US$ xx Mn by 2029.To know about the Research Methodology :- Request Free Sample Report
Fibrinogen Concentrates Market Dynamics
Fibrinogen is a soluble plasma glycoprotein. It is one of the blood clotting factors which are vital for blood clot formation. Fibrinogen pays attention is detailed for the treatment of acute bleeding incidents in patients with congenital fibrinogen deficiency, with afibrinogenemia and hypofibrinogenemia. It is a glycoprotein in vertebrates used as a medicinal drug for a blood disorder, which helps within the formation of blood clots. In severely bleeding patients, fibrinogen concentrate drastically improves whole blood clot firmness and decreases the postoperative transfusion necessities. The factors together with the upsurge in the use of fibrinogen pay attention to bleeding patients and for the treatment of congenital deficiencies propel the growth of the global market. Besides, the upward thrust in consciousness and issues referring to the health enhance the growth of the market. The upsurges in demand for fibrinogen concentrates, a rise in the range of instances of bleeding issues, and the increase in obtainability of fibrinogen products are the main factors anticipated to thrust the global fibrinogen concentrates marketplace. However, certain negative reactions including arterial thrombosis, chills, dyspnea, nausea, vomiting, and pulmonary embolism confine the growth.Fibrinogen concentrates Market Segment analysis
Based at the Application, the congenital fibrinogen deficiency segment is projected to grow at a CAGR of xx% for the duration of the forecast duration. Congenital Fibrinogen Deficiency is predicted to register a higher increase in the fibrinogen concentrate marketplace as a result of the better occurrence of hemophilia and improvement in products associated with fibrinogen. According to the National Hemophilia Foundation, the worldwide prevalence of hemophilia is not well known, but estimated at more than 400,000 people. Nearly 75% of people with hemophilia around the world still receive inadequate treatment or have no access to treatment market. Biotest's fibrinogen concentrate is presently being investigated clinically in a multinational segment I/III trial in sufferers with congenital fibrinogen deficiency. For the acquired fibrinogen deficiency Biotest conducts a Phase III examine in multiple European nations in patients with high blood loss throughout spine surgery. Therefore, the growing occurrence of bleeding problems and the safety and efficiency of human fibrinogen concentrate is anticipated to thrust the fibrinogen concentrate market growth in this segment.Fibrinogen concentrates Market Regional analysis
North America is projected to account for the largest market share during the forecast period. The U.S. is expected to account for the largest market share in North America, followed by Canada. Approximately 18,000 people are living with hemophilia in the United States. The market within the region is predicted to be compelled by an upsurge in focus on developing new treatment plans for rare blooding clotting issues and refining access to orphan drugs which are indicated for the treatment of rare diseases. Europe is probable to gain market share during the forecast length because of an upsurge in the number of market players presenting plasma-derived fibrinogen and an increase in the acceptance of new treatments in Germany, France, and the U.K. the fibrinogen concentrates. Acquired hemophilia, an unprecedented autoimmune disorder, is moderately predominant in the aged populace. Octapharma has introduced the booklet of recent information demonstrating that the fibrinogen pay attention fibryga® is an effective opportunity to cryoprecipitate for patients with severe bleeding at some stage in cardiac surgery. The statistics have been recently posted inside the Journal of the American Medical Association (JAMA) in 31st Oct 2019.Fibrinogen Concentrates Market Recent industry developments
15 March 2018 -Biotest AG today announces that the first patient in the pivotal phase III study in patients with acquired fibrinogen deficiency (study no. 995) has been treated. The objective of the report is to present a comprehensive analysis of the Global Fibrinogen concentrates Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Fibrinogen concentrates Market dynamics; structure by analysing the market segments and projects the Global Fibrinogen concentrates Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Fibrinogen concentrates Market make the report investor’s guide.Fibrinogen concentrates Market Scope: Inquire before buying
Fibrinogen Concentrates Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2022: US $ 2.86 Bn. Forecast Period 2023 to 2029 CAGR: 5.9% Market Size in 2029: US $ 4.28 Bn. Segments Covered: by Application Congenital Fibrinogen Deficiency Surgical Procedures by Type Human Fibrinogen Concentrates Animal Fibrinogen Concentrates Fibrinogen concentrates Market, By Regions
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Fibrinogen concentrates Market Key Players:
1. Baxter International Inc 2. Csl Behring 3. Green Cross International 4. Harbin Pacific Biopharmaceutical Co Ltd 5. Hualan Biological Engineering 6. Jiangxi Boya Bio-Pharmaceutical 7. Lfb Group 8. Profibrix Bv 9. Shanghai Raas 10. Shanghai Xinxing Medicine Co Ltd 11. Octapharma 12. ThermoFisher Scientific, Inc. 13. Merck KGaA 14. Affinity Biologicals, Inc. 15. Cayman Chemical 16. Molecular Innovations, Inc. 17. Akron Biotech 18. Enzo Life Sciences, Inc. 19. Bovogen Biologicals Pty Ltd Frequently Asked Questions: 1] What segments are covered in the Global Fibrinogen Concentrates Market report? Ans. The segments covered in the Market report are based on Application and Type 2] Which region is expected to hold the highest share in the Global Market? Ans. The North American region is expected to hold the highest share in Market. 3] What is the market size of the Global Market by 2029? Ans. The market size of the Global Market by 2029 is expected to reach US$ 4.28 Bn. 4] What is the forecast period for the Global Market? Ans. The forecast period for the Market is 2023-2029. 5] What was the market size of the Global Market in 2022? Ans. The market size of the Global Market in 2022 was valued at US$ 2.86 Bn.
Global Fibrinogen Concentrates Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Fibrinogen Concentrates Market Size, by Market Value (US$ Mn) (Volume) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Fibrinogen Concentrates Market Analysis and Forecast 6.1. Global Fibrinogen Concentrates Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Fibrinogen Concentrates Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Fibrinogen Concentrates Market Value Share Analysis, By Type 7.4. Global Fibrinogen Concentrates Market Size (US$ Mn) Forecast, By Type 7.5. Global Fibrinogen Concentrates Market Analysis, By Type 7.6. Global Fibrinogen Concentrates Market Attractiveness Analysis, By Type 8. Global Fibrinogen Concentrates Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Fibrinogen Concentrates Market Value Share Analysis, By Application 8.4. Global Fibrinogen Concentrates Market Size (US$ Mn) Forecast, By Application 8.5. Global Fibrinogen Concentrates Market Analysis, By Application 8.6. Global Fibrinogen Concentrates Market Attractiveness Analysis, By Application 9. Global Fibrinogen Concentrates Market Analysis, by Region 9.1. Global Fibrinogen Concentrates Market Value Share Analysis, by Region 9.2. Global Fibrinogen Concentrates Market Size (US$ Mn) Forecast, by Region 9.3. Global Fibrinogen Concentrates Market Attractiveness Analysis, by Region 10. North America Fibrinogen Concentrates Market Analysis 10.1. Key Findings 10.2. North America Fibrinogen Concentrates Market Overview 10.3. North America Fibrinogen Concentrates Market Value Share Analysis, By Type 10.4. North America Fibrinogen Concentrates Market Forecast, By Type 10.4.1. Human Fibrinogen Concentrates 10.4.2. Animal Fibrinogen Concentrates 10.5. North America Fibrinogen Concentrates Market Value Share Analysis, By Application 10.6. North America Fibrinogen Concentrates Market Forecast, By Application 10.6.1. Congenital Fibrinogen Deficiency 10.6.2. Surgical Procedures 10.7. North America Fibrinogen Concentrates Market Value Share Analysis, By Country 10.8. North America Fibrinogen Concentrates Market Forecast, By Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Fibrinogen Concentrates Market Analysis, By Country 10.10. U.S. Fibrinogen Concentrates Market Forecast, By Type 10.10.1. Human Fibrinogen Concentrates 10.10.2. Animal Fibrinogen Concentrates 10.11. U.S. Fibrinogen Concentrates Market Forecast, By Application 10.11.1. Congenital Fibrinogen Deficiency 10.11.2. Surgical Procedures 10.12. Canada Fibrinogen Concentrates Market Forecast, By Type 10.12.1. Human Fibrinogen Concentrates 10.12.2. Animal Fibrinogen Concentrates 10.13. Canada Fibrinogen Concentrates Market Forecast, By Application 10.13.1. Congenital Fibrinogen Deficiency 10.13.2. Surgical Procedures 10.14. North America Fibrinogen Concentrates Market Attractiveness Analysis 10.14.1. By Type 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Fibrinogen Concentrates Market Analysis 11.1. Key Findings 11.2. Europe Fibrinogen Concentrates Market Overview 11.3. Europe Fibrinogen Concentrates Market Value Share Analysis, By Type 11.4. Europe Fibrinogen Concentrates Market Forecast, By Type 11.4.1. Human Fibrinogen Concentrates 11.4.2. Animal Fibrinogen Concentrates 11.5. Europe Fibrinogen Concentrates Market Value Share Analysis, By Application 11.6. Europe Fibrinogen Concentrates Market Forecast, By Application 11.6.1. Congenital Fibrinogen Deficiency 11.6.2. Surgical Procedures 11.7. Europe Fibrinogen Concentrates Market Value Share Analysis, By Country 11.8. Europe Fibrinogen Concentrates Market Forecast, By Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Fibrinogen Concentrates Market Analysis, By Country 11.10. Germany Fibrinogen Concentrates Market Forecast, By Type 11.10.1. Human Fibrinogen Concentrates 11.10.2. Animal Fibrinogen Concentrates 11.11. Germany Fibrinogen Concentrates Market Forecast, By Application 11.11.1. Congenital Fibrinogen Deficiency 11.11.2. Surgical Procedures 11.12. U.K. Fibrinogen Concentrates Market Forecast, By Type 11.12.1. Human Fibrinogen Concentrates 11.12.2. Animal Fibrinogen Concentrates 11.13. U.K. Fibrinogen Concentrates Market Forecast, By Application 11.13.1. Congenital Fibrinogen Deficiency 11.13.2. Surgical Procedures 11.14. France Fibrinogen Concentrates Market Forecast, By Type 11.14.1. Human Fibrinogen Concentrates 11.14.2. Animal Fibrinogen Concentrates 11.15. France Fibrinogen Concentrates Market Forecast, By Application 11.15.1. Congenital Fibrinogen Deficiency 11.15.2. Surgical Procedures 11.16. Italy Fibrinogen Concentrates Market Forecast, By Type 11.16.1. Human Fibrinogen Concentrates 11.16.2. Animal Fibrinogen Concentrates 11.17. Italy Fibrinogen Concentrates Market Forecast, By Application 11.17.1. Congenital Fibrinogen Deficiency 11.17.2. Surgical Procedures 11.18. Spain Fibrinogen Concentrates Market Forecast, By Type 11.18.1. Human Fibrinogen Concentrates 11.18.2. Animal Fibrinogen Concentrates 11.19. Spain Fibrinogen Concentrates Market Forecast, By Application 11.19.1. Congenital Fibrinogen Deficiency 11.19.2. Surgical Procedures 11.20. Rest of Europe Fibrinogen Concentrates Market Forecast, By Type 11.20.1. Human Fibrinogen Concentrates 11.20.2. Animal Fibrinogen Concentrates 11.21. Rest of Europe Fibrinogen Concentrates Market Forecast, By Application 11.21.1. Congenital Fibrinogen Deficiency 11.21.2. Surgical Procedures 11.22. Europe Fibrinogen Concentrates Market Attractiveness Analysis 11.22.1. By Type 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Fibrinogen Concentrates Market Analysis 12.1. Key Findings 12.2. Asia Pacific Fibrinogen Concentrates Market Overview 12.3. Asia Pacific Fibrinogen Concentrates Market Value Share Analysis, By Type 12.4. Asia Pacific Fibrinogen Concentrates Market Forecast, By Type 12.4.1. Human Fibrinogen Concentrates 12.4.2. Animal Fibrinogen Concentrates 12.5. Asia Pacific Fibrinogen Concentrates Market Value Share Analysis, By Application 12.6. Asia Pacific Fibrinogen Concentrates Market Forecast, By Application 12.6.1. Congenital Fibrinogen Deficiency 12.6.2. Surgical Procedures 12.7. Asia Pacific Fibrinogen Concentrates Market Value Share Analysis, By Country 12.8. Asia Pacific Fibrinogen Concentrates Market Forecast, By Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Fibrinogen Concentrates Market Analysis, By Country 12.10. China Fibrinogen Concentrates Market Forecast, By Type 12.10.1. Human Fibrinogen Concentrates 12.10.2. Animal Fibrinogen Concentrates 12.11. China Fibrinogen Concentrates Market Forecast, By Application 12.11.1. Congenital Fibrinogen Deficiency 12.11.2. Surgical Procedures 12.12. India Fibrinogen Concentrates Market Forecast, By Type 12.12.1. Human Fibrinogen Concentrates 12.12.2. Animal Fibrinogen Concentrates 12.13. India Fibrinogen Concentrates Market Forecast, By Application 12.13.1. Congenital Fibrinogen Deficiency 12.13.2. Surgical Procedures 12.14. Japan Fibrinogen Concentrates Market Forecast, By Type 12.14.1. Human Fibrinogen Concentrates 12.14.2. Animal Fibrinogen Concentrates 12.15. Japan Fibrinogen Concentrates Market Forecast, By Application 12.15.1. Congenital Fibrinogen Deficiency 12.15.2. Surgical Procedures 12.16. ASEAN Fibrinogen Concentrates Market Forecast, By Type 12.16.1. Human Fibrinogen Concentrates 12.16.2. Animal Fibrinogen Concentrates 12.17. ASEAN Fibrinogen Concentrates Market Forecast, By Application 12.17.1. Congenital Fibrinogen Deficiency 12.17.2. Surgical Procedures 12.18. Rest of Asia Pacific Fibrinogen Concentrates Market Forecast, By Type 12.18.1. Human Fibrinogen Concentrates 12.18.2. Animal Fibrinogen Concentrates 12.19. Rest of Asia Pacific Fibrinogen Concentrates Market Forecast, By Application 12.19.1. Congenital Fibrinogen Deficiency 12.19.2. Surgical Procedures 12.20. Asia Pacific Fibrinogen Concentrates Market Attractiveness Analysis 12.20.1. By Type 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Fibrinogen Concentrates Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Fibrinogen Concentrates Market Overview 13.3. Middle East & Africa Fibrinogen Concentrates Market Value Share Analysis, By Type 13.4. Middle East & Africa Fibrinogen Concentrates Market Forecast, By Type 13.4.1. Human Fibrinogen Concentrates 13.4.2. Animal Fibrinogen Concentrates 13.5. Middle East & Africa Fibrinogen Concentrates Market Value Share Analysis, By Application 13.6. Middle East & Africa Fibrinogen Concentrates Market Forecast, By Application 13.6.1. Congenital Fibrinogen Deficiency 13.6.2. Surgical Procedures 13.7. Middle East & Africa Fibrinogen Concentrates Market Value Share Analysis, By Country 13.8. Middle East & Africa Fibrinogen Concentrates Market Forecast, By Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Fibrinogen Concentrates Market Analysis, By Country 13.10. GCC Fibrinogen Concentrates Market Forecast, By Type 13.10.1. Human Fibrinogen Concentrates 13.10.2. Animal Fibrinogen Concentrates 13.11. GCC Fibrinogen Concentrates Market Forecast, By Application 13.11.1. Congenital Fibrinogen Deficiency 13.11.2. Surgical Procedures 13.12. South Africa Fibrinogen Concentrates Market Forecast, By Type 13.12.1. Human Fibrinogen Concentrates 13.12.2. Animal Fibrinogen Concentrates 13.13. South Africa Fibrinogen Concentrates Market Forecast, By Application 13.13.1. Congenital Fibrinogen Deficiency 13.13.2. Surgical Procedures 13.14. Rest of Middle East & Africa Fibrinogen Concentrates Market Forecast, By Type 13.14.1. Human Fibrinogen Concentrates 13.14.2. Animal Fibrinogen Concentrates 13.15. Rest of Middle East & Africa Fibrinogen Concentrates Market Forecast, By Application 13.15.1. Congenital Fibrinogen Deficiency 13.15.2. Surgical Procedures 13.16. Middle East & Africa Fibrinogen Concentrates Market Attractiveness Analysis 13.16.1. By Type 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Fibrinogen Concentrates Market Analysis 14.1. Key Findings 14.2. South America Fibrinogen Concentrates Market Overview 14.3. South America Fibrinogen Concentrates Market Value Share Analysis, By Type 14.4. South America Fibrinogen Concentrates Market Forecast, By Type 14.4.1. Human Fibrinogen Concentrates 14.4.2. Animal Fibrinogen Concentrates 14.5. South America Fibrinogen Concentrates Market Value Share Analysis, By Application 14.6. South America Fibrinogen Concentrates Market Forecast, By Application 14.6.1. Congenital Fibrinogen Deficiency 14.6.2. Surgical Procedures 14.7. South America Fibrinogen Concentrates Market Value Share Analysis, By Country 14.8. South America Fibrinogen Concentrates Market Forecast, By Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Fibrinogen Concentrates Market Forecast, By Type 14.9.1. Human Fibrinogen Concentrates 14.9.2. Animal Fibrinogen Concentrates 14.10. Brazil Fibrinogen Concentrates Market Forecast, By Application 14.10.1. Congenital Fibrinogen Deficiency 14.10.2. Surgical Procedures 14.11. Mexico Fibrinogen Concentrates Market Forecast, By Type 14.11.1. Human Fibrinogen Concentrates 14.11.2. Animal Fibrinogen Concentrates 14.12. Mexico Fibrinogen Concentrates Market Forecast, By Application 14.12.1. Congenital Fibrinogen Deficiency 14.12.2. Surgical Procedures 14.13. Rest of South America Fibrinogen Concentrates Market Forecast, By Type 14.13.1. Human Fibrinogen Concentrates 14.13.2. Animal Fibrinogen Concentrates 14.14. Rest of South America Fibrinogen Concentrates Market Forecast, By Application 14.14.1. Congenital Fibrinogen Deficiency 14.14.2. Surgical Procedures 14.15. South America Fibrinogen Concentrates Market Attractiveness Analysis 14.15.1. By Type 14.15.2. By Application 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition 15.3. Matrix 15.3.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.3.2. New Product Launches and Product Enhancements 15.3.3. Market Consolidation 15.3.4. M&A by Regions, Investment and Applications 15.3.5. M&A Key Players, Forward Integration and Backward Integration 15.4. Company Profiles: Key Players 15.4.1. Baxter International Inc 15.4.1.1. Company Overview 15.4.1.2. Financial Overview 15.4.1.3. Product Portfolio 15.4.1.4. Business Strategy 15.4.1.5. Recent Developments 15.4.1.6. Company Footprint 15.4.2. Csl Behring 15.4.3. Green Cross International 15.4.4. Harbin Pacific Biopharmaceutical Co Ltd 15.4.5. Hualan Biological Engineering 15.4.6. Jiangxi Boya Bio-Pharmaceutical 15.4.7. Lfb Group 15.4.8. Profibrix Bv 15.4.9. Shanghai Raas 15.4.10. Shanghai Xinxing Medicine Co Ltd 15.4.11. SOctapharma 15.4.12. SThermoFisher Scientific, Inc. 15.4.13. SMerck KGaA 15.4.14. SAffinity Biologicals, Inc. 15.4.15. SCayman Chemical 15.4.16. SMolecular Innovations, Inc. 15.4.17. SAkron Biotech 15.4.18. SEnzo Life Sciences, Inc. 15.4.19. SBovogen Biologicals Pty Ltd. 16. Primary Key Insights